B-FLEXION is a private, entrepreneurial investment firm that partners with capital to meet the goal of delivering value over generations, while also contributing to society. B-FLEXION has offices across Europe and in the United States.

B-FLEXION

B-FLEXION is a private, entrepreneurial investment firm that partners with sophisticated capital to meet the shared goal of delivering exceptional value over generations, while also contributing positively to society.
 
With offices across Europe and in the US, B-FLEXION invests in – and partners with – asset managers across sectors including Private Equity, Venture Capital, Infrastructure, Technology, Real Estate, Hedge Funds, Public and Private Credit, and Public Securities. It also continues to drive expansion by growing operating businesses in transformative industries. In keeping with – and building upon – its heritage, these are principally in the fields of Life Sciences, Healthcare Services and Digital Health.

We are very pleased to announce that Securis Investment Partners LLP and Twelve Capital, two independent asset management specialists in Insurance-Linked Securities (‘ILS’), plan to merge. This will create a leading founder-led business and one of the largest, most experienced ILS managers globally with $7.8bln in assets under management.

The combination of Securis Investment Partners LLP – in which B-FLEXION has been a major stakeholder since 2012 – and Twelve Capital ensures continued alignment of interests as the merger preserves its independence and client-centric approach. Securis Investment Partners LLP was founded in 2005 and remains an industry pioneer in public and private ILS, with almost two decades of experience. Twelve Capital which was founded in 2010 specialises in insurance investments and is an established market leader in catastrophe bonds with over 14 years’ experience.

With complementary investment-driven cultures and expertise, the combined business will benefit from enhanced investment capabilities and market access, alongside greater ability to invest in proprietary technology.

https://lnkd.in/gmHhKgGQ

B-Flexion is proud to be an anchor investor in Landfair Capital's first fund, its European Dislocated Opportunities fund

https://lnkd.in/e92ZJ88g

Newest member of the Gurnet Point Capital portfolio is Paratek Pharmaceuticals. More below...

Metric
Company Name	B-FLEXION
Symbol
MSH ID	COM:BFLEXION
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Management
Country	EU
Stage
Employee Count
Website	bflexion.com
LinkedIn	b-flexion
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BFLE

COM:BFLEXION

B-FLEXION

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue